American Renal Associates Holdings, Inc
ARA
ARA was delisted on the 25th of January, 2021.
56 hedge funds and large institutions have $178M invested in American Renal Associates Holdings, Inc in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 15 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $184M → $178M (-$5.64M)
3.26% less ownership
Funds ownership: 84.2% → 80.94% (-3.3%)
11% less funds holding
Funds holding: 63 → 56 (-7)
15% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 20
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $55K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$730K |
| 2 |
GC
Globeflex Capital
San Diego,
California
|
+$631K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$578K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$262K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$2.04M |
| 2 |
BlackRock
New York
|
-$1.56M |
| 3 |
JP Morgan Chase
New York
|
-$969K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$288K |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$186K |
ARA Hedge Fund Activity: Q2 2020 in Review
56 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q2 2020, worth a combined $178M — down 3.1% from $184M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of ARA and 8 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 17 added.
The largest buyer was Morgan Stanley, adding an estimated $730K. The largest seller was Wells Fargo, cutting an estimated $2.04M.
- 56 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q2 2020, down from 63 in Q1 2020.
- Funds reported $178M of American Renal Associates Holdings, Inc stock for Q2 2020, down 3.1% quarter-over-quarter.
- 8 funds opened new American Renal Associates Holdings, Inc positions in Q2 2020 and 15 closed out, a net change of -7 holders.
- The largest American Renal Associates Holdings, Inc buyer in Q2 2020 was Morgan Stanley, an estimated $730K added.
- The largest American Renal Associates Holdings, Inc seller in Q2 2020 was Wells Fargo, an estimated $2.04M sold.
Based on aggregated 13F filings for Q2 2020.